Symbol="IMTXW"
AssetType="Common Stock"
Name="immatics biotechnologies GmbH"
Description="Immatics NV is dedicated to the discovery of targets for cancer immunotherapies. The company is headquartered in Tuebingen, Germany."
CIK="1809196"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="PAUL EHRLICH-STRASSE 15, TUBINGEN, DE"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="673004000"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="None"
DividendPerShare="None"
DividendYield="0"
EPS="None"
RevenuePerShareTTM="0"
ProfitMargin="-1.564"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="0"
ReturnOnEquityTTM="0"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="0"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.942"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="None"
num_52WeekHigh="4.41"
num_52WeekLow="1.25"
num_50DayMovingAverage="0"
num_200DayMovingAverage="0"
SharesOutstanding="0"
DividendDate="None"
ExDividendDate="None"
symbol="IMTXW"
open="3.35"
high="3.35"
low="3.11"
price="3.11"
volume="3241.00"
latest_trading_day="2023-07-12"
previous_close="3.11"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="49"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="49"
Volume_recent_avg="14495"
Change_recent_avg="-0.02"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.57"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="49"
Aroon_momentum_negative="51"
image_negative_thumbnail_id_1="1143"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0176.jpeg"
image_negative_thumbnail_id_2="111"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_neutral_thumbnail_id_1="597"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0002.jpeg"
image_neutral_thumbnail_id_2="544"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_positive_thumbnail_id_1="955"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_positive_thumbnail_id_2="647"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0061.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
